A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) (WSK-V102D).
Conditions: COVID-19 Interventions: Biological: Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) (WSK-V102D); Biological: Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102); Biological: Placebo Sponsors: WestVac Biopharma Co., Ltd.; WestVac Biopharma (Guangzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
Conditions: SARS-CoV2 Infection; Influenza A; Influenza B; Respiratory Syncytial Virus (RSV) Interventions: Device: COVID-19/Flu A/Flu B/RSV Test Kit Sponsors: EDAN Instruments Inc.; MDx CRO (MED IVD HEALTHTECH S.L.) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography
Conditions: Long Covid19 Interventions: Device: dynamic chest radiography Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
VYD222 produced high serum virus neutralizing antibody titer levels in immunocompromised participants
Data supportive of an immunobridging approach to the EVADE study of adintrevimab
Overall favorable safety and tolerability profile of VYD222... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 18, 2023 Category: Pharmaceuticals Source Type: clinical trials
Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
Conditions: Long Covid19; Exercise Intolerance, Riboflavin-Responsive Interventions: Behavioral: Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise; Behavioral: Light Stretching/Breathing Exercises Sponsors: Columbia University; New York University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
A Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2
Conditions: PLWH; Covid-19; Clinical Features; Prognosis Interventions: Other: SARS-CoV-2 Sponsors: The Second Affiliated Hospital of Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants
Conditions: COVID-19 Pandemic Interventions: Diagnostic Test: two-dimensional speckle tracking echocardiography Sponsors: Haiyan Wang Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
A Pilot Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Conditions: Multiple Sclerosis; Long COVID; Long Covid19; Obese; Obesity; Obesity, Morbid; Acute Leukemia in Remission Interventions: Drug: Liraglutide Pen Injector [Saxenda]; Other: Medication Diary Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
STREngthening COVID-19 Surveillance in Africa
Conditions: COVID-19; SARS CoV 2 Infection; COVID-19 Pandemic Sponsors: Institut de Recherche pour le Developpement; European and Developing Countries Clinical Trials Partnership (EDCTP); Institut de Recherche Clinique du B énin; Barcelona Institute for Global Health; Ministère de la Santé - Bénin; Ministère de la Santé et de Hygiène Publique - Burkina Faso Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
Conditions: Attention Deficit Hyperactivity Disorder (ADHD) Interventions: Behavioral: Internet-Assisted behavioral parent training (IA-BPT) Sponsors: Wuhan Mental Health Centre Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa
Conditions: COVID-19; SARS CoV 2 Infection; COVID-19 Pandemic Sponsors: Institut de Recherche pour le Developpement; European and Developing Countries Clinical Trials Partnership (EDCTP); Institut de Recherche Clinique du B énin; Barcelona Institute for Global Health; Ministère de la Santé - Bénin; Ministère de la Santé et de Hygiène Publique - Burkina Faso Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Conditions: Multiple Sclerosis; Long COVID; Long Covid19; Obese; Obesity; Obesity, Morbid; Acute Leukemia in Remission Interventions: Drug: Liraglutide Pen Injector [Saxenda]; Other: Medication Diary Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Exercise training using an app on physical cardiovascular function individuals with post-covid-19 syndrome
Conditions: Post-Acute COVID-19 Syndrome Interventions: Behavioral: Exercise; Behavioral: Control Sponsors: University of Nove de Julho Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
A Phase 1 Trial of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination
Conditions: SARS-CoV-2; COVID-19 Vaccine Interventions: Biological: 30 μg dose of LYB002V14; Biological: 60μg dose of LYB002V14; Biological: placebo Sponsors: Guangzhou Patronus Biotech Co., Ltd.; Yantai Patronus Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Conditions: Influenza; COVID-19; SARS-COV-2 Infection; Other Respiratory Viruses; Perinatal Morbidity; Infant Morbidity Interventions: Other: Exposures Sponsors: Boston University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Lata Medical Research Foundation, Nagpur Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
